These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 29210318)

  • 41. The Impact of Inhaler Device Regimen in Patients with Asthma or COPD.
    Usmani OS; Hickey AJ; Guranlioglu D; Rawson K; Stjepanovic N; Siddiqui S; Dhand R
    J Allergy Clin Immunol Pract; 2021 Aug; 9(8):3033-3040.e1. PubMed ID: 33901714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers.
    Grant AC; Walker R; Hamilton M; Garrill K
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):474-85. PubMed ID: 26372466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Respimat Soft Mist Inhaler, a Novel Inhaled Drug Delivery Device.
    Perriello EA; Sobieraj DM
    Conn Med; 2016; 80(6):359-64. PubMed ID: 27509644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhaled drug delivery in the hands of the patient.
    Lavorini F
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):414-8. PubMed ID: 25238005
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Patients with COPD have low adherence to inhaled medicine].
    Toettenborg S; Topp M; Ingebrigtsen T; Lange P
    Ugeskr Laeger; 2014 Feb; 176(6A):V05130288. PubMed ID: 25347438
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of inhalation therapy in chronic obstructive pulmonary disease and asthma.
    Pavia D
    Respirology; 1997; 2 Suppl 1():S5-10. PubMed ID: 9400688
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Suboptimal inhaler medication adherence and incorrect technique are common among chronic obstructive pulmonary disease patients.
    Sriram KB; Percival M
    Chron Respir Dis; 2016 Feb; 13(1):13-22. PubMed ID: 26396159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of patients hospitalized for exacerbations of chronic obstructive pulmonary disease: comparison of an oral/metered-dose inhaler regimen and an intravenous/nebulizer regimen.
    Shortall SP; Blum J; Oldenburg FA; Rodgerson L; Branscombe JM; Harrow EM
    Respir Care; 2002 Feb; 47(2):154-8. PubMed ID: 11812271
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of combined indacaterol and glycopyrronium bromide (QVA149) for the treatment of COPD in Japan.
    Horita N; Kaneko T
    Int J Chron Obstruct Pulmon Dis; 2015; 10():813-22. PubMed ID: 25960646
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers.
    Yu AP; Guérin A; Ponce de Leon D; Ramakrishnan K; Wu EQ; Mocarski M; Blum S; Setyawan J
    J Med Econ; 2011; 14(4):486-96. PubMed ID: 21679019
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors affecting the selection of an inhaler device for COPD and the ideal device for different patient profiles. Results of EPOCA Delphi consensus.
    Miravitlles M; Soler-Cataluña JJ; Alcázar B; Viejo JL; García-Río F
    Pulm Pharmacol Ther; 2018 Feb; 48():97-103. PubMed ID: 29031616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting.
    Yawn BP; Colice GL; Hodder R
    Int J Chron Obstruct Pulmon Dis; 2012; 7():495-502. PubMed ID: 22888221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Considerations for managing chronic obstructive pulmonary disease in the elderly.
    Taffet GE; Donohue JF; Altman PR
    Clin Interv Aging; 2014; 9():23-30. PubMed ID: 24376347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro validation of a Respimat® adapter for delivery of inhaled bronchodilators during mechanical ventilation.
    Dellweg D; Wachtel H; Höhn E; Pieper MP; Barchfeld T; Köhler D; Glaab T
    J Aerosol Med Pulm Drug Deliv; 2011 Dec; 24(6):285-92. PubMed ID: 21870959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Device use errors with soft mist inhalers: A global systematic literature review and meta-analysis.
    Navaie M; Dembek C; Cho-Reyes S; Yeh K; Celli BR
    Chron Respir Dis; 2020; 17():1479973119901234. PubMed ID: 31984767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the bronchodilator effects of salbutamol delivered via a metered-dose inhaler with spacer, a dry-powder inhaler, and a jet nebulizer in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Tsukino M; Hajiro T; Mishima M; Izumi T
    Respiration; 1999; 66(2):119-23. PubMed ID: 10202314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation and importance of different types of inhaler device in patients with chronic obstructive lung disease.
    Öztürk C; Aldağ Y; Yılmaz Demirci N
    Tuberk Toraks; 2017 Jun; 65(2):69-79. PubMed ID: 28990885
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Real-life use of inhaler devices for chronic obstructive pulmonary disease in primary care].
    Girodet PO; Raherison C; Abouelfath A; Lignot S; Depont F; Moore N; Molimard M
    Therapie; 2003; 58(6):499-504. PubMed ID: 15058493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.